$142.37
3.52.52%
At Close: -
$142.25
-0.12-0.08%
After Hours: 7:47 PM EDT
15 minutes delayed
Novo Nordisk
NVONYSE
Novo Nordisk (NYSE:NVO) 주식, 실적 예상치, EPS, 및 매출
Novo Nordisk은(는) 분기별로 실적을 보고합니다. 이 분기별 실적 보고서를 통해 투자자는 3개월 동안 회사의 재무 결과를 엿볼 수 있습니다. 실적 보고서에는 거의 항상 EPS 및 매출 결과가 포함됩니다..
Earnings Date
Aug 8
EPS Estimate
$0.810
Quarterly Revenue Estimate
$10.1B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$244.2B
Analyze the earnings history of Novo Nordisk using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | Novo Nordisk | $0.63 | $0.81 | — | — | $7.94B | $10.06B | — | — | 08/08/2024 | Get Alert |
| NVO | Novo Nordisk | $0.64 | $0.74 | $0.83 | 12.16% | $7.69B | $9.07B | $9.52B | 4.93% | 05/02/2024 | Get Alert |
| NVO | Novo Nordisk | $0.41 | $0.65 | $0.71 | 9.08% | $6.44B | $8.82B | $9.50B | 7.75% | 01/31/2024 | Get Alert |
| NVO | Novo Nordisk | $0.43 | $0.71 | $0.73 | 2.82% | $6.17B | $7.91B | $8.58B | 8.42% | 11/02/2023 | Get Alert |
| NVO | Novo Nordisk | $0.42 | $0.64 | $0.63 | -1.56% | $5.91B | $7.97B | $7.94B | -0.39% | 08/10/2023 | Get Alert |
| NVO | Novo Nordisk | $0.47 | $0.64 | $0.64 | 0.00% | $6.34B | $7.65B | $7.69B | 0.55% | 05/04/2023 | Get Alert |
| NVO | Novo Nordisk | $0.37 | $0.43 | $0.41 | -4.65% | $5.90B | $6.84B | $6.44B | -5.91% | 02/01/2023 | Get Alert |
| NVO | Novo Nordisk | $0.42 | $0.42 | $0.43 | 2.38% | $5.64B | $5.89B | $6.17B | 4.82% | 11/02/2022 | Get Alert |
| NVO | Novo Nordisk | $0.43 | $0.41 | $0.42 | 2.44% | $5.32B | $5.81B | $5.91B | 1.76% | 08/03/2022 | Get Alert |
| NVO | Novo Nordisk | $0.44 | $0.40 | $0.47 | 17.50% | $5.48B | $5.59B | $6.34B | 13.43% | 04/29/2022 | Get Alert |
| NVO | Novo Nordisk | $0.32 | $0.36 | $0.37 | 2.78% | $5.14B | $5.67B | $5.90B | 3.99% | 02/02/2022 | Get Alert |
| NVO | Novo Nordisk | $0.35 | $0.39 | $0.42 | 7.69% | $4.86B | $5.35B | $5.64B | 5.51% | 11/03/2021 | Get Alert |
| NVO | Novo Nordisk | $0.34 | $0.39 | $0.43 | 10.26% | $4.43B | $5.11B | $5.32B | 4.15% | 08/05/2021 | Get Alert |
| NVO | Novo Nordisk | $0.38 | $0.42 | $0.44 | 4.76% | $5.08B | $5.29B | $5.48B | 3.59% | 05/05/2021 | Get Alert |
| NVO | Novo Nordisk | $0.28 | $0.32 | $0.32 | 0.00% | $4.86B | $5.35B | $5.14B | -3.89% | 02/03/2021 | Get Alert |
| NVO | Novo Nordisk | $0.32 | $0.36 | $0.35 | -2.78% | $4.54B | $4.89B | $4.86B | -0.70% | 10/30/2020 | Get Alert |
| NVO | Novo Nordisk | $0.31 | — | $0.34 | — | $4.51B | — | $4.43B | — | 08/06/2020 | Get Alert |
| NVO | Novo Nordisk | $0.33 | — | $0.38 | — | $4.39B | — | $5.08B | — | 05/06/2020 | Get Alert |
| NVO | Novo Nordisk | $0.27 | $0.28 | $0.28 | 0.00% | $4.55B | $4.76B | $4.86B | 2.16% | 02/05/2020 | Get Alert |
| NVO | Novo Nordisk | $0.29 | $0.31 | $0.32 | 3.23% | $4.33B | $4.54B | $4.54B | 0.04% | 11/01/2019 | Get Alert |
| NVO | Novo Nordisk | $0.34 | $0.32 | $0.31 | -3.12% | $4.38B | $4.67B | $4.51B | -3.34% | 08/09/2019 | Get Alert |
Novo Nordisk (NVO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $0.83 | $0.74 | 12.2 % |
| Dec 2023 | 2024-01-31 | $0.71 | $0.65 | 9.08 % |
| Sep 2023 | 2023-11-02 | $0.73 | $0.71 | 2.82 % |
| Jun 2023 | 2023-08-10 | $0.63 | $0.64 | -1.56 % |
Novo Nordisk (NVO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $9.52B | $9.07B | 4.93 % |
| Dec 2023 | 2024-01-31 | $9.50B | $8.82B | 7.75 % |
| Sep 2023 | 2023-11-02 | $8.58B | $7.91B | 8.42 % |
| Jun 2023 | 2023-08-10 | $7.94B | $7.97B | -0.39 % |
FAQ
When is Novo Nordisk (NYSE:NVO) reporting earnings?
Novo Nordisk (NVO) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Novo Nordisk (NYSE:NVO)?
The Actual EPS was $0.83, which beat the estimate of $0.74.
What were Novo Nordisk’s (NYSE:NVO) revenues?
The Actual Revenue was $9.5B, which beat the estimate of $9.1B.
Browse earnings estimates, EPS, and revenue on all stocks.